These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26018599)

  • 1. A randomised phase IIb trial to assess the efficacy of ReCharge ice cream in preventing chemotherapy-induced diarrhoea.
    Perez D; Sharples KJ; Broom R; Jeffery M; Proctor J; Hinder V; Pollard S; Edwards J; Simpson A; Scott J; Benge S; Krissansen G; Geursen A; Palmano K; MacGibbon A; Keefe D; Findlay M
    Support Care Cancer; 2015 Nov; 23(11):3307-15. PubMed ID: 26018599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised double-blind placebo-controlled phase II study of AGI004 for control of chemotherapy-induced diarrhoea.
    Coyle VM; Lungulescu D; Toganel C; Niculescu A; Pop S; Ciuleanu T; Cebotaru C; Devane J; Martin M; Wilson RH
    Br J Cancer; 2013 Mar; 108(5):1027-33. PubMed ID: 23462724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial.
    Rosenoff SH; Gabrail NY; Conklin R; Hohneker JA; Berg WJ; Warsi G; Maloney J; Benedetto JJ; Miles EA; Zhu W; Anthony L
    J Support Oncol; 2006 Jun; 4(6):289-94. PubMed ID: 16805331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy.
    Rosenoff SH
    Eur J Cancer Care (Engl); 2004 Sep; 13(4):380-3. PubMed ID: 15305907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial.
    Hoff PM; Saragiotto DF; Barrios CH; del Giglio A; Coutinho AK; Andrade AC; Dutra C; Forones NM; Correa M; Portella Mdo S; Passos VQ; Chinen RN; van Eyll B
    J Clin Oncol; 2014 Apr; 32(10):1006-11. PubMed ID: 24516038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-induced diarrhoea in dogs and its management with smectite: Results of a monocentric open-label randomized clinical trial.
    Fournier Q; Serra JC; Williams C; Bavcar S
    Vet Comp Oncol; 2021 Mar; 19(1):25-33. PubMed ID: 32562450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced diarrhoea.
    Gibson RJ; Stringer AM
    Curr Opin Support Palliat Care; 2009 Mar; 3(1):31-5. PubMed ID: 19365159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy.
    Keefe DM; Elting LS; Nguyen HT; Grunberg SM; Aprile G; Bonaventura A; Selva-Nayagam S; Barsevick A; Koczwara B; Sonis ST
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):675-80. PubMed ID: 25055935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide in the treatment of severe chemotherapy-induced diarrhea.
    Zidan J; Haim N; Beny A; Stein M; Gez E; Kuten A
    Ann Oncol; 2001 Feb; 12(2):227-9. PubMed ID: 11300329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidance on the management of diarrhoea during cancer chemotherapy.
    Andreyev J; Ross P; Donnellan C; Lennan E; Leonard P; Waters C; Wedlake L; Bridgewater J; Glynne-Jones R; Allum W; Chau I; Wilson R; Ferry D
    Lancet Oncol; 2014 Sep; 15(10):e447-60. PubMed ID: 25186048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315.
    Zachariah B; Gwede CK; James J; Ajani J; Chin LJ; Donath D; Rosenthal SA; Kane BL; Rotman M; Berk L; Kachnic LA
    J Natl Cancer Inst; 2010 Apr; 102(8):547-56. PubMed ID: 20339140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea.
    Chatterjee S; Kar P; Das T; Ray S; Gangulyt S; Rajendiran C; Mitra M
    J Assoc Physicians India; 2013 Oct; 61(10):708-12. PubMed ID: 24772726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
    du Bois A; Kristensen G; Ray-Coquard I; Reuss A; Pignata S; Colombo N; Denison U; Vergote I; Del Campo JM; Ottevanger P; Heubner M; Minarik T; Sevin E; de Gregorio N; Bidziński M; Pfisterer J; Malander S; Hilpert F; Mirza MR; Scambia G; Meier W; Nicoletto MO; Bjørge L; Lortholary A; Sailer MO; Merger M; Harter P;
    Lancet Oncol; 2016 Jan; 17(1):78-89. PubMed ID: 26590673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy induced diarrhea.
    Richardson G; Dobish R
    J Oncol Pharm Pract; 2007 Dec; 13(4):181-98. PubMed ID: 18045778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamine for chemotherapy induced diarrhea: a meta-analysis.
    Sun J; Wang H; Hu H
    Asia Pac J Clin Nutr; 2012; 21(3):380-5. PubMed ID: 22705427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial.
    Paz-Ares L; de Marinis F; Dediu M; Thomas M; Pujol JL; Bidoli P; Molinier O; Sahoo TP; Laack E; Reck M; Corral J; Melemed S; John W; Chouaki N; Zimmermann AH; Visseren-Grul C; Gridelli C
    Lancet Oncol; 2012 Mar; 13(3):247-55. PubMed ID: 22341744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
    Chapple C; Schneider T; Haab F; Sun F; Whelan L; Scholfield D; Dragon E; Mangan E
    BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of chemotherapy-induced diarrhea with the synthetic enkephalin BW942C: a randomized trial with placebo in patients receiving cisplatin.
    Kris MG; Gralla RJ; Clark RA; Tyson LB; Groshen S
    J Clin Oncol; 1988 Apr; 6(4):663-8. PubMed ID: 3282034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study.
    Cappuzzo F; Ciuleanu T; Stelmakh L; Cicenas S; Szczésna A; Juhász E; Esteban E; Molinier O; Brugger W; Melezínek I; Klingelschmitt G; Klughammer B; Giaccone G;
    Lancet Oncol; 2010 Jun; 11(6):521-9. PubMed ID: 20493771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies.
    Rosenoff S
    Support Care Cancer; 2004 Aug; 12(8):561-70. PubMed ID: 15160318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.